Program

8th. InterAmerican Oncology Conference
“Current Status and Future of Anti-Cancer Therapies”
October 17-18, 2019
Universidad Católica Argentina
Pabellón San José, Juan Pablo II Meeting Room
Puerto Madero, Buenos Aires, Argentina

 

THURSDAY, OCTOBER 17th.
09:00 AM – 09:15 AM OPENING REMARKS
Román Perez Soler
NEW ANTICANCER THERAPIES I
Chairpersons: Claudia Bagnes, Carlos Silva
09:15 AM – 09:45 AM Promising Novel Agents in Early Clinical Trials:
Alex A. Adjei, Rochester, USA
09:45 AM – 10:15 AM Biomarkers for Cancer Immunotherapy:
Antoni Ribas, Los Angeles, USA
10:15 AM – 10:30 AM Round Table and Questions with Speakers and Chairpersons
10:30 AM – 10:45 AM Break

LUNG CANCER
Chairpersons: Carlos Bas, Mauro Orlando
10:45 AM – 11:15 AM What’s new in the Management of SCLC and Mesothelioma:
Alex A. Adjei, Rochester, USA
11:15 AM – 11:45 AM Advances in the Treatment of Advanced NSCLC:
Román Pérez Soler, New York, USA
11:45 AM – 12:05 PM Round Table and Questions with Speakers and Chairpersons
12:05 PM – 12:35 PM Lunch Boxes Sponsored by MSD
12:35 PM – 01:35 PM MSD SATELLITE SYMPOSIUM:
Why Not Delay Pembrolizumab in NSCLC?

Carlos Barrios, Porto Alegre, Brazil


01:35 PM – 01:50 PM Coffee Break Sponsored by Amgen
01:50 PM – 02:50 PM AMGEN SATELLITE SYMPOSIUM:
Precision Medicine in mCRC: Sequencing, Rechallenging and Role of Liquid Biopsy

Guillem Argiles, Barcelona, Spain
02:50 PM – 03:05 PM Break

GI CANCER
Chairperson: Guillermo Méndez
03:05 PM – 03:35 PM Novel Therapies in GI Cancer:
Josep Tabernero, Barcelona, Spain
03:35 PM – 03:45 PM Round Table and Questions with Speakers and Chairpersons


03:45 PM – 04:00 PM Coffee Break Sponsored by BMS
04:00 PM – 05:00 PM BMS SATELLITE SYMPOSIUM:
Overall Survival as the Treatment Objective in First Line Renal Cancer: From Clinical Trials to Daily Practice

Ignacio Duran, Sevilla, Spain
GU CANCER
Chairpersons: Enrique Díaz Cantón, Juan Pablo Sade
05:00 PM – 05:30 PM Novel Therapies in Prostate and Renal Cancer:
Charles Drake, New York , USA
05:30 PM – 05:50 PM The Evolution of Targeted Therapy and Checkpoint Inhibitors in Bladder Cancer:
Joaquim Bellmunt, Boston, USA
05:50 PM – 06:05 PM Round Table and Questions with Speakers and Chairpersons

 

Adjourn for the day

FRIDAY, OCTOBER 18th.
09:00 AM – 09:15 AM OPENING REMARKS
Román Pérez Soler
NEW ANTICANCER THERAPIES II
Chairpersons: Valeria Denninghoff, Daniel Lewi, Carlos Silva
09:15 AM – 09:35 AM Galectins: Emerging Checkpoints in Immune and Vascular Signaling Programs in Cancer:
Gabriel Rabinovich, Buenos Aires, Argentina
09:35 AM – 09:55 AM Novel Combination Approaches for Cancer Immunotherapy:
Charles Drake, New York , USA
09:55 AM – 10:10 AM Round Table and Questions with Speakers and Chairpersons
10:10 AM – 10:25 AM Break
10:25 AM – 11:05 AM MERCK PFIZER ALLIANCE SATELLITE SYMPOSIUM:
IO, New Treatment Paradigm for MCC

Gabriela Cinat , Buenos Aires, Argentina
Michael Wong, Texas, USA
11:05 AM – 11:20 AM Coffee Break Sponsored by Merck Pfizer Alliance

MELANOMA
Chairperson: Gabriela Cinat
11:20 AM – 11:50 AM New Treatments in Melanoma:
Antoni Ribas, Los Angeles, USA
11:50 AM – 12:05 PM Round Table and Questions with Speakers and Chairpersons
12:05 PM – 12:20 PM Break

BREAST CANCER
Chairpersons: Valeria Cáceres, Victoria Costanzo, María Viniegra
12:20 PM – 12:50 PM Challenges in the Genomic Selection of Patients:
Carlos Barrios, Porto Alegre, Brazil
12:50 PM – 01:20 PM CDK4/6 Inhibitors in Breast Cancer: Latest Clinical Trials and Mechanisms of Drug Resistance:
Carlos L. Arteaga, Dallas, USA
01:20 PM – 01:35 PM Round Table and Questions with Speakers and Chairpersons
01:35 PM – 02:00 PM Break


02:00 PM – 02:15 PM Coffee Break Sponsored by Amgen
02:15 PM – 03:15 PM AMGEN SATELLITE SYMPOSIUM:
Why is MRD Testing Relevant in Multiple Myeloma?

Andrzej Jakubowiak, Chicago,USA
Flow Cytometry in MRD Detection in MM and Complementarity with Imaging
Bruno Paiva, Salamanca, Spain
03:15 PM – 03:30 PM Break

HEMATOLOGICAL MALIGNANCIES
Chairpersons: Carolina Pavlovsky, Julio Sánchez Avalos, Marta Zerga
03:30 PM – 04:00 PM Multiple Myeloma:
Kenneth C. Anderson, Boston, USA
04:00 PM – 04:30 PM New Developments in Lymphoma:
Stephen Ansell, Rochester, USA
04:30 PM – 05:00 PM Novel Drug Development in Leukemia:
Jorge Cortés, Houston, USA
05:00 PM – 05:15 PM Round Table and Questions with Speakers and Chairpersons
05:15 PM CLOSING REMARKS
Roman Pérez Soler